5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat

M. A. Carroll, M. P. Garcia, J R Falck, J. C. McGiff

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

We have reported that 5,6-epoxyeicosatrienoic acid (5,6-EET) was the only cytochrome P-450-dependent arachidonic acid (AA) epoxide to dilate the isolated, perfused caudal artery of the rat. We have investigated the mechanisms by which 5,6-EET dilates the rat-tail artery by studying the effect of deendothelialization and inhibition of AA metabolic pathways (cyclooxygenase, lipoxygenase, and cytochrome P-450 monooxygenase) on the vascular action of the epoxide. Rat isolated caudal arteries were perfused with Krebs-Henseleit solution at 37°C, pH 7.4, and gassed with 95% O2-5% CO2. Arterial tone was elevated with phenylephrine; acetylcholine (0.5 nmol) was used to detect the presence of intact, functional endothelium. Doses of 5,6-EET, from 6.25 to 25.0 nmol, were injected close-arterially. After obtaining control responses, the same doses were randomly retested after deendothelialization or in the presence of inhibitors of AA metabolism. Removal of the endothelium decreased by 70% the vasodilator responses to 5,6-EET. The endothelial dependency was a function of the epoxide interacting with cyclooxygenase of the endothelium, because indomethacin (3 μM) and aspirin (50 μM) prevented the vasodilator response to 5,6-EET while not affecting the response to acetylcholine. SKF-525A (1.1 μM) and metyrapone (150 μM) did not affect the responses to the 5,6-EET, whereas clotrimazole (0.7 μM) and nordihydroguariaretic acid (2.5 μM) had nonspecific effects, decreasing responses to 5,6-EET and acetylcholine. Because 5,6-EET failed to stimulate detectable release of prostanoids into the effluent from the caudal artery, we conclude that 5,6-EET requires conversion by cyclooxygenase for expression of its vasoactivity.

Original languageEnglish (US)
Pages (from-to)1082-1088
Number of pages7
JournalCirculation Research
Volume67
Issue number5
StatePublished - 1990

Fingerprint

Epoxy Compounds
Prostaglandin-Endoperoxide Synthases
Arteries
Arachidonic Acid
Acetylcholine
Endothelium
Vasodilator Agents
Cytochrome P-450 Enzyme System
Proadifen
Clotrimazole
Metyrapone
5,6-epoxy-8,11,14-eicosatrienoic acid
Lipoxygenase
Phenylephrine
Metabolic Networks and Pathways
Indomethacin
Aspirin
Prostaglandins
Blood Vessels
Tail

Keywords

  • arachidonic acid
  • cyclooxygenase
  • cytochrome P-450 monooxygenase
  • epoxides
  • vasoactivity

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. / Carroll, M. A.; Garcia, M. P.; Falck, J R; McGiff, J. C.

In: Circulation Research, Vol. 67, No. 5, 1990, p. 1082-1088.

Research output: Contribution to journalArticle

Carroll, M. A. ; Garcia, M. P. ; Falck, J R ; McGiff, J. C. / 5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. In: Circulation Research. 1990 ; Vol. 67, No. 5. pp. 1082-1088.
@article{b2d7ba1fc51f4c04a2cedae6f587b5f7,
title = "5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat",
abstract = "We have reported that 5,6-epoxyeicosatrienoic acid (5,6-EET) was the only cytochrome P-450-dependent arachidonic acid (AA) epoxide to dilate the isolated, perfused caudal artery of the rat. We have investigated the mechanisms by which 5,6-EET dilates the rat-tail artery by studying the effect of deendothelialization and inhibition of AA metabolic pathways (cyclooxygenase, lipoxygenase, and cytochrome P-450 monooxygenase) on the vascular action of the epoxide. Rat isolated caudal arteries were perfused with Krebs-Henseleit solution at 37°C, pH 7.4, and gassed with 95{\%} O2-5{\%} CO2. Arterial tone was elevated with phenylephrine; acetylcholine (0.5 nmol) was used to detect the presence of intact, functional endothelium. Doses of 5,6-EET, from 6.25 to 25.0 nmol, were injected close-arterially. After obtaining control responses, the same doses were randomly retested after deendothelialization or in the presence of inhibitors of AA metabolism. Removal of the endothelium decreased by 70{\%} the vasodilator responses to 5,6-EET. The endothelial dependency was a function of the epoxide interacting with cyclooxygenase of the endothelium, because indomethacin (3 μM) and aspirin (50 μM) prevented the vasodilator response to 5,6-EET while not affecting the response to acetylcholine. SKF-525A (1.1 μM) and metyrapone (150 μM) did not affect the responses to the 5,6-EET, whereas clotrimazole (0.7 μM) and nordihydroguariaretic acid (2.5 μM) had nonspecific effects, decreasing responses to 5,6-EET and acetylcholine. Because 5,6-EET failed to stimulate detectable release of prostanoids into the effluent from the caudal artery, we conclude that 5,6-EET requires conversion by cyclooxygenase for expression of its vasoactivity.",
keywords = "arachidonic acid, cyclooxygenase, cytochrome P-450 monooxygenase, epoxides, vasoactivity",
author = "Carroll, {M. A.} and Garcia, {M. P.} and Falck, {J R} and McGiff, {J. C.}",
year = "1990",
language = "English (US)",
volume = "67",
pages = "1082--1088",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - 5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat

AU - Carroll, M. A.

AU - Garcia, M. P.

AU - Falck, J R

AU - McGiff, J. C.

PY - 1990

Y1 - 1990

N2 - We have reported that 5,6-epoxyeicosatrienoic acid (5,6-EET) was the only cytochrome P-450-dependent arachidonic acid (AA) epoxide to dilate the isolated, perfused caudal artery of the rat. We have investigated the mechanisms by which 5,6-EET dilates the rat-tail artery by studying the effect of deendothelialization and inhibition of AA metabolic pathways (cyclooxygenase, lipoxygenase, and cytochrome P-450 monooxygenase) on the vascular action of the epoxide. Rat isolated caudal arteries were perfused with Krebs-Henseleit solution at 37°C, pH 7.4, and gassed with 95% O2-5% CO2. Arterial tone was elevated with phenylephrine; acetylcholine (0.5 nmol) was used to detect the presence of intact, functional endothelium. Doses of 5,6-EET, from 6.25 to 25.0 nmol, were injected close-arterially. After obtaining control responses, the same doses were randomly retested after deendothelialization or in the presence of inhibitors of AA metabolism. Removal of the endothelium decreased by 70% the vasodilator responses to 5,6-EET. The endothelial dependency was a function of the epoxide interacting with cyclooxygenase of the endothelium, because indomethacin (3 μM) and aspirin (50 μM) prevented the vasodilator response to 5,6-EET while not affecting the response to acetylcholine. SKF-525A (1.1 μM) and metyrapone (150 μM) did not affect the responses to the 5,6-EET, whereas clotrimazole (0.7 μM) and nordihydroguariaretic acid (2.5 μM) had nonspecific effects, decreasing responses to 5,6-EET and acetylcholine. Because 5,6-EET failed to stimulate detectable release of prostanoids into the effluent from the caudal artery, we conclude that 5,6-EET requires conversion by cyclooxygenase for expression of its vasoactivity.

AB - We have reported that 5,6-epoxyeicosatrienoic acid (5,6-EET) was the only cytochrome P-450-dependent arachidonic acid (AA) epoxide to dilate the isolated, perfused caudal artery of the rat. We have investigated the mechanisms by which 5,6-EET dilates the rat-tail artery by studying the effect of deendothelialization and inhibition of AA metabolic pathways (cyclooxygenase, lipoxygenase, and cytochrome P-450 monooxygenase) on the vascular action of the epoxide. Rat isolated caudal arteries were perfused with Krebs-Henseleit solution at 37°C, pH 7.4, and gassed with 95% O2-5% CO2. Arterial tone was elevated with phenylephrine; acetylcholine (0.5 nmol) was used to detect the presence of intact, functional endothelium. Doses of 5,6-EET, from 6.25 to 25.0 nmol, were injected close-arterially. After obtaining control responses, the same doses were randomly retested after deendothelialization or in the presence of inhibitors of AA metabolism. Removal of the endothelium decreased by 70% the vasodilator responses to 5,6-EET. The endothelial dependency was a function of the epoxide interacting with cyclooxygenase of the endothelium, because indomethacin (3 μM) and aspirin (50 μM) prevented the vasodilator response to 5,6-EET while not affecting the response to acetylcholine. SKF-525A (1.1 μM) and metyrapone (150 μM) did not affect the responses to the 5,6-EET, whereas clotrimazole (0.7 μM) and nordihydroguariaretic acid (2.5 μM) had nonspecific effects, decreasing responses to 5,6-EET and acetylcholine. Because 5,6-EET failed to stimulate detectable release of prostanoids into the effluent from the caudal artery, we conclude that 5,6-EET requires conversion by cyclooxygenase for expression of its vasoactivity.

KW - arachidonic acid

KW - cyclooxygenase

KW - cytochrome P-450 monooxygenase

KW - epoxides

KW - vasoactivity

UR - http://www.scopus.com/inward/record.url?scp=0025153829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025153829&partnerID=8YFLogxK

M3 - Article

C2 - 2121384

AN - SCOPUS:0025153829

VL - 67

SP - 1082

EP - 1088

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -